ARPA-H Funding, Brain Wearables, & Nanotech Biosensing | Longevity News Roundup — Week 10, 2026
The U.S. ARPA‑H agency announced a $144 million PROSPR program to accelerate human health‑span trials, awarding $30.8 million to Cambrian BioPharma for a next‑generation rapamycin analog and $22 million to Linnaeus Therapeutics for repurposed oncology drugs. Meanwhile, startups are pushing wearable and digital health frontiers: Temple unveiled a head‑worn device that continuously measures cerebral blood flow and brain activity, and Berlin‑based YOU(th) raised $4.5 million for an AI‑driven smartphone platform that extracts 50 digital biomarkers in under two minutes. Richter acquired Celmatix’s ovarian biology assets to develop therapies targeting ovarian aging, and Swiss nanotech firm Xsensio secured funding for a minimally invasive skin sensor that tracks metabolites, electrolytes and inflammation in real time. Together, these initiatives signal a shift toward proactive, biomarker‑driven longevity interventions across government, pharma and venture‑backed innovators.
MedTech Innovator APAC Pitch Event 1 (Online)
The MedTech Innovator APAC Pitch Event 1 marked the launch of the 2026 road‑tour series, an online showcase of ten early‑stage medtech companies spanning in‑vitro diagnostics, digital health, wearables, and AI‑driven software. Hosted by managing director Frederick Nabik from Tokyo,...
Life Sciences Consulting Explained | Careers, AI, and Industry Trends (2026)
A recent Management Consulted panel brought together leaders from Guidehouse, Clarkston Consulting, ClearView Healthcare Partners, and Roland Berger to dissect the current state of life‑sciences consulting. The discussion highlighted how artificial intelligence is delivering tangible value in drug development, how precision...
Meet Hepatologist Michael Schilsky, MD
The video features hepatologist Michael Schilsky, MD, outlining how liver transplantation has progressed from a pioneering procedure in the 1970s to a routine component of modern hepatology. He explains that transplants now address both severe acute liver failure and, more...
Dr. Ben Feringa | 2025 Feynman Prize Winner
Dr. Ben Feringa, 2016 Nobel laureate in chemistry, was honored with the 2025 Feynman Prize and delivered a lecture on the art of building molecular switches and motors. He framed the discussion around dynamic molecular systems that bridge chemistry, physics,...
Adeno-Associated Virus-Mediated Gene Therapy - Advances, Immune Challenges, and Research Innovations
At FDA Grand Rounds, Dr. Ronit Mazur of CBER reviewed advances and persistent immunological challenges in adeno-associated virus (AAV)–mediated gene therapy, outlining how AAV’s favorable safety and durability have driven a surge in FDA approvals since 2017. She summarized AAV...
Alzheimer Therapeutics Program | Mass General Brigham
The Mass General Brigham Alzheimer Therapeutics Program introduces anti‑amyloid infusion therapy for individuals diagnosed with early‑stage Alzheimer’s disease, positioning the health system at the forefront of disease‑modifying treatment options. The program targets amyloid plaques—protein aggregates that disrupt neuronal communication—by administering monoclonal...
HEALEY ALS Platform Trial Webinar: February 26, 2026 | Neurofilament Analysis
The Healey ALS Platform Trial webinar focused on neurofilament light chain (NFL) as a biomarker in amyotrophic lateral sclerosis. Clinician‑researcher Dr. James Barry and biostatistician Jenny Wing explained NFL’s biology, its detection in cerebrospinal fluid and blood, and why it...
Accelerating Genome Analysis: A Primer on an Ongoing Journey - CANU UDG Lecture, 08.06.2023
Professor H., a computer‑science veteran with stints at Microsoft Research, Intel, AMD and Google, opened the lecture by framing genome analysis as the next frontier where information technology meets biology. He highlighted his 17‑year journey from early research on genome‑aware...
Healey Community Q&A Webinar: February 12, 2026 | Expanded Access
The Healey Community Q&A Webinar on February 12, 2026 featured Dr. James Berry of Massachusetts General Hospital alongside Rapa Therapeutics representatives. They reported that the RAPA-501 Expanded Access Protocol has successfully reached its enrollment goals, providing broader treatment options for...
Making Biologics Orally Available With Vivtex's Thomas Von Erlach, Ph.D.
The interview with Thomas von Erlach, Ph.D., co‑founder and CEO of Vivex, focuses on the company’s breakthrough gastrointestinal‑on‑a‑chip platform that makes biologic drugs orally bioavailable, a stark contrast to traditional injections or IVs. Von Erlach outlines how the technology, conceived...
MRNA Therapy (NORD)
The video explains how messenger RNA (mRNA) is being engineered as a protein‑replacement therapy for a range of inherited disorders. By copying DNA’s instructions into a transportable mRNA strand, scientists can deliver the missing or malfunctioning protein blueprint to cells...
Implementing Emerging Technologies in Digital Biology (15 Minutes)
The video outlines how digital biology— the convergence of computational tools with life‑science research— is reshaping discovery, healthcare, and industry. By digitizing genomes, proteins and whole organisms, scientists can model, simulate and iterate experiments far faster than traditional wet‑lab methods. Key...
Why Culture Beats Technology | Daphne Koller
Daphne Koller, co‑founder of Coursera, argues that culture, not technology, is the primary driver of lasting organizational performance. She recounts an early interview where a senior candidate asked, “What would you like the culture here to be?” prompting her realization that...
High-Throughput Screening, CRISPR & Immunotherapy - The Sidi Chen Lab at Yale School of Medicine
The Sidi Chen laboratory at Yale School of Medicine is leveraging high‑throughput CRISPR screening to map every gene that influences immune‑cell behavior in cancer settings. By perturbing the full complement of ~20,000 human genes in vivo, the team seeks to pinpoint...
Three Generations of Age Tests
Scientists are developing biological ‘age’ tests that measure DNA methylation—small chemical tags added to specific sites on the genome—that change with environment, lifestyle and disease. These epigenetic markers don’t alter the genetic code but influence gene reading and are associated...
🎙️ Targeting Inflammaging with AI
Scienta introduced EVA, an AI model designed to combat inflammaging. EVA integrates multi‑omic preclinical and clinical data to map inflammatory pathways linked to age‑related diseases. The platform proposes novel therapeutic targets and compounds aimed at restoring youthful immune signaling. The...
Biological Age Testing: Can Your DNA Tell Us More Than Your Blood Pressure?
The video explains biological age tests that use DNA methylation patterns to estimate how fast a person is aging versus their chronological age. Early “first-generation” clocks estimate calendar age, second-generation measures like GrimAge predict mortality and disease risk, and newer...
Nanoplastics, mRNA Therapy, & Drug Approvals | Longevity News Roundup — Week 9, 2026
Recent longevity news highlights nanoplastics in brains, a pioneering mRNA therapy, and regulatory shifts accelerating anti‑aging drug development. Researchers found ultra‑small plastic particles accumulating in Alzheimer‑affected brain tissue, independent of age. Klothea launched a phase 1b trial of AKL003 mRNA to...
TT3A: Minimally Invasive Aortic Solution | MedTech World Middle East 2026
TT3A, led by CEO Alexandro Pito, is developing a transcatheter combined valve-and-stent graft to treat pathologies of the ascending aorta—an area currently treatable only by complex open-heart surgery. The startup says its minimally invasive device could halve mortality and hospitalization...
Drosophila Development Csir Net Part 1 | Drosophila Development Cleavage and Gastrulation
The video provides a systematic overview of Drosophila embryogenesis, tracing the transition from a single‑nucleus egg through syncytial cleavage, blastoderm formation, and eventual cellularization. It emphasizes the insect’s syncytial specification, where nuclei divide in a common cytoplasm before membranes partition...
3 Things to Know About Moderna’s mRNA Flu Vaccine and Its FDA Application
The video examines the FDA’s sudden reversal on Moderna’s mRNA influenza vaccine, shifting from an initial refusal to a green light for a fast‑track review aimed at adults aged 65 and older. The agency had already examined the application, but...
Walk With Me: Joseph Wu, Cardiologist Studying Stem Cells and Heart Disease
Joseph Wu, a Stanford professor of medicine and radiology, leads the Stanford Cardiovascular Institute in developing patient‑specific cardiac cells derived from a person’s own blood. By reprogramming blood cells into pluripotent stem cells and then coaxing them to become beating...
Health Compass | Season 3
Season 3 of Stanford Medicine’s Health Compass podcast, hosted by Dr. Maya Adam, examines how scientific discoveries move from the lab to patient care. Episodes pair engineers, data scientists, and clinicians to unpack translational hurdles in rare genetic diseases, stroke,...
Butterfly Skin: Caring for Patients with Epidermolysis Bullosa | Ep.1: Health Compass Podcast
The Health Compass podcast’s first episode spotlights epidermolysis bullosa, a rare genetic skin disorder often called “butterfly skin,” that makes even light touch painful. Stanford clinicians Jean Tang, MD, PhD, and Peter Marinkovich, MD, discuss how decades of research are...
A New Spin on Stroke Treatment | Ep.3: Health Compass Podcast
A stroke caused by a blocked artery demands immediate, precise intervention, as minutes dictate outcomes. At Stanford, radiologist Jeremy Heit and mechanical engineer Renee Zhao have joined forces to redesign clot removal using image‑guided, minimally invasive technologies. Their work leverages...
How a Winding Path Led to a Life-Saving Test | Ep.2: Health Compass Podcast
Purvesh Khatri, a Stanford professor with a background in electronics, software, and computational immunology, unveiled a rapid blood test that detects sepsis within minutes. The assay shortens diagnosis time dramatically, enabling clinicians to start targeted therapy far earlier than traditional...
Neurotechnology’s Role Beyond Drugs in Treating Brain Disorders
The video spotlights neurotechnology as a burgeoning alternative to pharmaceuticals for brain‑disorder treatment, emphasizing its capacity to directly modulate neural activity without crossing the blood‑brain barrier. Speakers highlight that synchronized light and sound—so‑called sensory ramps—can activate brain circuits, while brain‑computer interfaces,...
P&S: Architectures & Algorithms for Health & Life Sciences - L1: Course Introduction (Spr 2026)
Welcome to the first lecture of the ETH Zurich “Architectures & Algorithms for Health and Life Sciences” project‑seminar, presented by PhD candidate Nika Mansuriyasi. The session outlines the course’s scope, objectives, and its relevance amid accelerating biotechnological data generation. Mansuriyasi explains...
Sub-Q Bionics Company Showcase | MedTech World Middle East 2026
At MedTech World Middle East 2026, Sub‑Q Bionics CEO Jordan Pollack unveiled a “bionic lymph node,” an implantable microporous device with an integrated pump that continuously drains excess lymphatic fluid. The system syncs to a cloud‑based platform that applies AI...
Malta as a Living Lab for Precision Oncology | MedTech World Middle East 2026
At MedTech World Middle East 2026, Prof. Christian Scerri unveiled a plan to turn Malta into a living lab for precision oncology, leveraging its single national health system, compact ecosystem, and EU‑aligned regulatory framework. He outlined a roadmap that includes...
GCC MedTech Boom: Market, Funding & Scaling | MedTech World Middle East 2026
At MedTech World Middle East 2026, a panel of GCC health leaders highlighted the region’s rapid shift from a pure healthcare consumer to a burgeoning hub for MedTech, biotech, and digital health innovation. National visions and transformation strategies are driving...
The Surprising Impact of Drug Price Negotiation on Clinical Trials
The podcast examines a new Health Affairs paper that tracks how the Inflation Reduction Act’s Medicare drug‑price negotiation provision has affected biopharmaceutical clinical‑trial activity. Dr. So Young Kang and co‑authors compare industry‑sponsored trial initiations from 2015‑2024, focusing on firms directly hit...
The Conjugation Conundrum: The Realities of Conjugated LNP Manufacturing
The discussion centers on the emerging complexities of conjugated lipid nanoparticle (LNP) manufacturing, a shift from standard platform processes toward targeted RNA delivery. Sujit explains that adding a biologic ligand to LNPs forces manufacturers to revisit every process parameter—viscosity, shear...
The “Art” Of the Linker: Complexity, Biodegradability, and Scale in Active LNP R&D
The panel examined the emerging “active” delivery paradigm for lipid nanoparticle (LNP) therapeutics, focusing on the added layers of complexity introduced by ligand‑modified formulations and the need for robust R&D pipelines. Participants contrasted passive LNPs with active, ligand‑decorated versions, highlighting...
The Challenges Novel Lipids Pose For mRNA-LNP Manufacturing
Novel lipid chemistries are accelerating mRNA‑LNP innovation, but they also upend established manufacturing platforms. According to CMC consultant Sujit Jain, each new lipid class forces a fresh round of process development, demanding new impurity profiling strategies and vendor qualification. The...
Novel Lipid Chemistries & Their Impact on Passive LNP Delivery
In a recent Advancing RNA Live session, Dominik Witzigmann of NanoVation and John Zuris of Stealth Co dissected emerging lipid chemistries that enhance passive lipid nanoparticle (LNP) delivery. They highlighted breakthroughs in ionizable lipids, helper lipids, and PEG‑lipids that improve...
How Microfluidics & QbD Are Maturing LNP Manufacturing
In a recent discussion, CMC consultant Sujit Jain and NanoVation CEO Dominik Witzigmann highlighted how microfluidic platforms combined with Quality‑by‑Design (QbD) principles are transforming lipid nanoparticle (LNP) production for mRNA therapeutics. They noted that continuous‑flow microfluidics now enable precise control...
Primates, Patents, & Progress: Advancements In Rational LNP Design
In a recent Advancing RNA Live segment, Dominik Witzigmann of NanoVation Therapeutics and John Zuris of Stealth Co discussed the latest scientific breakthroughs shaping lipid nanoparticle (LNP) design. They highlighted rational, data‑driven approaches that improve particle stability, targeting precision, and...
The Evolving CMC Landscape for mRNA-LNPs
In a recent Advancing RNA Live segment, CMC consultant Sujit Jain outlined the current maturity levels across process development, analytical methods, and supply‑chain logistics for mRNA‑LNP products. He highlighted that COVID‑19 vaccines and liver‑targeted therapeutics now operate on a reproducible,...
Investing in Biotech with Verdad Capital
The Yet Another Value podcast featured Verdad Capital’s Dan Rasmmanson and Greg Obachen discussing their new research paper on quantitative, value‑oriented investing in biotech. The duo explains why biotech, despite representing roughly a quarter of the Russell 2000, is routinely...
FDA Direct: Combating Rare Diseases at the FDA
The FDA Direct town hall marked Rare Disease Day with a candid conversation between FDA leaders Jim and Elizabeth, who both have personal ties to rare‑disease advocacy. Their discussion highlighted the agency’s growing focus on rare‑disease patients, the establishment...
The Hidden Link Between Inflammation and Cholesterol | Behind the Breakthrough
The video explains that atherosclerotic plaque is primarily driven by chronic inflammation rather than merely cholesterol accumulation, highlighting a paradigm shift in heart‑disease research. Researchers at NYU Langone discovered that macrophages ingest cholesterol using receptors meant for bacteria, which stalls the...
NIH SciBites: Pursuing Lab-Grown Organs Through Stem Cell Studies
The video spotlights NIH post‑baccalaureate fellow Jack’s work on engineering lab‑grown organs, focusing on how stem cells must be coaxed through differentiation to become functional heart, lung or other tissues. Jack explains that differentiation hinges on the three‑dimensional arrangement of DNA....
Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray
The Huberman Lab podcast features Dr. Tony Wyss‑Coray discussing how factors circulating in young blood can rejuvenate the aging brain and body. Using parabiosis—surgically joining the circulatory systems of young and old mice—his lab demonstrated that young‑derived proteins reactivate neural...
A New Approach to Alzheimer’s? Leucadia Therapeutics | MedTech World Middle East 2026
Leucadia Therapeutics unveiled Arethusta, a minimally invasive glymphatic modulator aimed at restoring cerebrospinal fluid outflow to combat Alzheimer’s disease. The company links impaired drainage at the cribriform plate to early Alzheimer’s pathology and presented pre‑clinical ferret data supporting the approach....
The Art and Science of 3D Bioprinting (4 Minutes)
The four‑minute video demystifies 3D bioprinting, describing how engineers replace plastic filament with living bio‑ink to fabricate tissues and organs layer by layer. It explains the workflow: designers create detailed digital blueprints, custom bio‑ink mixtures supply cells and nutrients, printers deposit...
Ecological Niche BSc 3rd Year | Ecological Niche Explained for Csir Net Life Science
The video lectures on ecological niche, defining it as the functional role of a species within its ecosystem, and distinguishes it from habitat, which is merely the physical location where an organism lives. It explains that a niche comprises habitat plus...
Regulatory Evolution to Expedite Drug Development in Japan: A PMDA Initiatives
The video outlines PMDA’s latest regulatory reforms aimed at accelerating drug development in Japan. Since its 2004 inception, the agency has cut review cycles dramatically, yet a growing “drug loss” problem persists as 35% of drugs approved in the United...
Growing Role of Chinese Pharmaceutical Firms in Global Supply Chains
The video highlights how Chinese biotech firms are reshaping global drug supply chains, with Shanghai’s “Pharma Valley” emerging as a hub. Goldman Sachs data show that 46% of new drug molecules entering human trials in the first half of 2025...
